It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly outperform the market - but in the process, they risk under-performance. For ...

Funding will advance minimally invasive brain interface platform already tested in 10 patients and accelerate development of a cortical foundation model for next-generation BCIs. Neurosoft ...

After a surgical first, a Swiss neurotech company is getting closer to treating severe neurological disorders with its unique brain interface designed as a safe alternative to existing brain implants.

Neurosoft Bioelectronics has raised $7.5m to advance the development of its brain-computer interface (BCI). The Swiss company's oversubscribed seed financing round was led by Skybound Venture Capital, ...

Neurosoft Bioelectronics, a company developing a minimally invasive brain-computer interface, has closed a $7.5 million oversubscribed seed funding round, bringing its total funding to more than $20 ...

Neurosoft (NRST) has delivered a 15.870% change over the past year, with a 52-week range between 0.460 and 0.930. What Is the Average Daily Trading Volume of Neurosoft (NRST)? The average daily ...

ALAMEDA, Calif. & GENEVA, February 20, 2026--(BUSINESS WIRE)--Science Corporation, the pioneering full-stack neural engineering company focused on restoring and extending life, and Neurosoft ...

* As a consequence the total share capital of Neurosoft will amount to 8,954,607.90 euros divided into 25,584,594 shares, that comes from the sum of the 25,000,000 Neurosoft ordinary shares and the ...

GENEVA & NEW YORK--(BUSINESS WIRE)--Neurosoft Bioelectronics, a neurotechnology company developing scalable and soft brain-computer interfaces (BCIs), today announced that it has raised a $7.5 million ...